AoDImEmFwgwTjHHks
Will I have to work shifts? side effects of caverta Tecfidera, which is widely expected to become the No. 1 oraltreatment for the disease, with annual sales of more than $3billion, was launched in April. Biogen is expected to reportsales for the drug's first few weeks on the market on Thursday.